Increased glucocorticoid secretion is frequent in mood disorders and is normalized by long-term antidepressant therapy. Many antidepressants act by increasing central serotonin transmission. We investigated the effects of a serotonin precursor, indole-pyruvic acid (IPA), in an animal model of depression based on repeated exposure to unpredictable stress. Rats were divided in groups, and IPA (20 mg/kg), the tricyclic antidepressant imipramine (IMI) (5 mg/kg), or vehicle was administered daily during 3 weeks of repeated exposure to various stressors according to the procedure described by Katz et al [Katz RJ, Roth KA, Carroll BJ (1981): Neurosci Biobehav Rev 5:247-251]. After treatment, rats were evaluated for stress-induced exploratory behavior and killed 24 hr later. Serum corticosterone levels and glucocorticoid receptor (GR) immunoreactivity (IR) in the nuclei of neurons located in the hippocampal subregion CA1 were also measured. Rats exposed to repeated stress showed a lower exploratory behavior score (p < 0.01), higher basal corticosterone levels (p < 0.01), and stronger GR IR in the hippocampus (p < 0.05) than control rats. All of these effects were antagonized by IMI treatment. IPA administration did not affect the behavioral response induced by repeated stress (p < 0.01) but normalized serum corticosterone levels. In addition, IPA treatment produced a decrease in GR IR (p < 0.05 versus control group) that was not modified by exposure to repeated stress. Differences in the drug effects suggest that (1) the dose of IPA used for treatment was not sufficient to produce behavior effects; (2) a side product of IPA in vivo transformation, kynurenic acid, may have affected glutamate transmission, interacting with the behavioral outcomes; (3) the serotonin precursor IPA and the uptake blocker IMI may have produced different adaptive changes in hippocampal serotonin transmission, as indicated by nuclear GR IR measurements.

Indole-pyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression / Biagini, Giuseppe; MERLO PICH, Emilio; Carani, Cesare; Marrama, Paolo; J. A., Gustafsson; K., Fuxe; Agnati, Luigi Francesco. - In: BIOLOGICAL PSYCHIATRY. - ISSN 0006-3223. - STAMPA. - 33:(1993), pp. 712-719.

Indole-pyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression

BIAGINI, Giuseppe;MERLO PICH, Emilio;CARANI, Cesare;MARRAMA, Paolo;AGNATI, Luigi Francesco
1993

Abstract

Increased glucocorticoid secretion is frequent in mood disorders and is normalized by long-term antidepressant therapy. Many antidepressants act by increasing central serotonin transmission. We investigated the effects of a serotonin precursor, indole-pyruvic acid (IPA), in an animal model of depression based on repeated exposure to unpredictable stress. Rats were divided in groups, and IPA (20 mg/kg), the tricyclic antidepressant imipramine (IMI) (5 mg/kg), or vehicle was administered daily during 3 weeks of repeated exposure to various stressors according to the procedure described by Katz et al [Katz RJ, Roth KA, Carroll BJ (1981): Neurosci Biobehav Rev 5:247-251]. After treatment, rats were evaluated for stress-induced exploratory behavior and killed 24 hr later. Serum corticosterone levels and glucocorticoid receptor (GR) immunoreactivity (IR) in the nuclei of neurons located in the hippocampal subregion CA1 were also measured. Rats exposed to repeated stress showed a lower exploratory behavior score (p < 0.01), higher basal corticosterone levels (p < 0.01), and stronger GR IR in the hippocampus (p < 0.05) than control rats. All of these effects were antagonized by IMI treatment. IPA administration did not affect the behavioral response induced by repeated stress (p < 0.01) but normalized serum corticosterone levels. In addition, IPA treatment produced a decrease in GR IR (p < 0.05 versus control group) that was not modified by exposure to repeated stress. Differences in the drug effects suggest that (1) the dose of IPA used for treatment was not sufficient to produce behavior effects; (2) a side product of IPA in vivo transformation, kynurenic acid, may have affected glutamate transmission, interacting with the behavioral outcomes; (3) the serotonin precursor IPA and the uptake blocker IMI may have produced different adaptive changes in hippocampal serotonin transmission, as indicated by nuclear GR IR measurements.
1993
33
712
719
Indole-pyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression / Biagini, Giuseppe; MERLO PICH, Emilio; Carani, Cesare; Marrama, Paolo; J. A., Gustafsson; K., Fuxe; Agnati, Luigi Francesco. - In: BIOLOGICAL PSYCHIATRY. - ISSN 0006-3223. - STAMPA. - 33:(1993), pp. 712-719.
Biagini, Giuseppe; MERLO PICH, Emilio; Carani, Cesare; Marrama, Paolo; J. A., Gustafsson; K., Fuxe; Agnati, Luigi Francesco
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/307833
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 41
social impact